136 related articles for article (PubMed ID: 38408449)
1. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics.
Hu X; Zhang D; Huang L; Zeng Z; Su Y; Chen S; Lin X; Hong S
ACS Biomater Sci Eng; 2024 Mar; 10(3):1830-1842. PubMed ID: 38408449
[TBL] [Abstract][Full Text] [Related]
2. A Smart, Autocatalytic, DNAzyme Biocircuit for in Vivo, Amplified, MicroRNA Imaging.
Wei J; Wang H; Wu Q; Gong X; Ma K; Liu X; Wang F
Angew Chem Int Ed Engl; 2020 Apr; 59(15):5965-5971. PubMed ID: 31961985
[TBL] [Abstract][Full Text] [Related]
3. Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma.
Zheng W; Li X; Zou H; Xu Y; Li P; Zhou X; Wu M
Int J Nanomedicine; 2022; 17():3217-3237. PubMed ID: 35924259
[TBL] [Abstract][Full Text] [Related]
4. A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells.
Wu M; Xiong H; Zou H; Li M; Li P; Zhou Y; Xu Y; Jian J; Liu F; Zhao H; Wang Z; Zhou X
Acta Biomater; 2018 Apr; 70():211-226. PubMed ID: 29452275
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma.
Mandal M; Banerjee I; Mandal M
Colloids Surf B Biointerfaces; 2022 Dec; 220():112899. PubMed ID: 36252537
[TBL] [Abstract][Full Text] [Related]
6. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
7. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target?
Karami Fath M; Pourbagher Benam S; Kouhi Esfahani N; Shahkarami N; Shafa S; Bagheri H; Shafagh SG; Payandeh Z; Barati G
Clin Transl Oncol; 2023 Aug; 25(8):2350-2364. PubMed ID: 37000290
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma and tumor-suppressor gene therapy.
Xu HJ
Ophthalmol Clin North Am; 2003 Dec; 16(4):621-9. PubMed ID: 14741002
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract][Full Text] [Related]
10. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract][Full Text] [Related]
11. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
14. Cell membrane coated smart two-dimensional supraparticle for
Zhang D; Ye Z; Liu H; Wang X; Hua J; Ling Y; Wei L; Xia Y; Sun S; Xiao L
Nanotheranostics; 2021; 5(3):275-287. PubMed ID: 33654654
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial determinants for treatment decisions in familial retinoblastoma.
Soliman SE; Ulster A; MacDonald H; VandenHoven C; Toi A; Hèon E; Gallie B
Ophthalmic Genet; 2017; 38(4):392-394. PubMed ID: 28085520
[No Abstract] [Full Text] [Related]
16. A DNAzyme dual-feedback autocatalytic exponential amplification biocircuit for microRNA imaging in living cells.
Huang X; Li Z; Shi Y; Zhang Y; Shen T; Chen M; Huang Z; Tong Y; Liu SY; Guo J; Zou X; Dai Z
Biosens Bioelectron; 2023 Dec; 241():115669. PubMed ID: 37688849
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma.
Muniyandi A; Jensen NR; Devanathan N; Dimaras H; Corson TW
Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):18. PubMed ID: 38180770
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Technologies and Strategies for the Management of Retinoblastoma.
Gudiseva HV; Berry JL; Polski A; Tummina SJ; O'Brien JM
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835688
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
